0001213900-22-008933.txt : 20220223
0001213900-22-008933.hdr.sgml : 20220223
20220223160920
ACCESSION NUMBER: 0001213900-22-008933
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: David Matthew T
CENTRAL INDEX KEY: 0001811612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 22663622
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
doc4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-18
true
0001410098
CorMedix Inc.
CRMD
0001811612
David Matthew T
C/O CORMEDIX INC. 300 CONNELL DRIVE
SUITE 4200
BERKELEY HEIGHTS
NJ
07922
false
true
false
false
Interim CEO and CFO
Common Stock
3150.0000
D
Stock Option (Right to Buy Common Stock)
4.0300
2022-02-18
4
A
false
100000.0000
0.0000
A
2032-02-18
Common Stock
100000.0000
100000.0000
D
Stock Option (Right to Buy Common Stock)
5.5600
2031-11-01
Common Stock
125000.0000
125000.0000
D
Stock Option (Right to Buy Common Stock)
8.3200
2031-01-11
Common Stock
80000.0000
80000.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-05-11
Common Stock
125000.0000
125000.0000
D
Stock Option (Right to Buy Common Stock)
4.0800
2030-05-11
Common Stock
125000.0000
125000.0000
D
These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
/s/ Matthew T. David
2022-02-23